Drug Repurposing
Immagine generata dall'IA
Experts flag shingles vaccine, sildenafil and riluzole as leading Alzheimer’s repurposing candidates
Riportato dall'IA Immagine generata dall'IA Verificato
A University of Exeter-led study funded by Alzheimer’s Society has identified three already-approved medicines—the shingles vaccine Zostavax, sildenafil (Viagra) and riluzole—as top “priority” candidates to be tested in clinical trials for Alzheimer’s disease, after a structured review of 80 existing drugs by an international expert panel.